https://www.marketscreener.com/quote/stock/VANDA-PHARMACEUTICALS-INC-16742/news/Vanda-Pharma-Says-FDA-Identified-Deficiencies-in-Hetlioz-Review-That-Preclude-Discussion-of-Labeling-45884556/?utm_source=telegram&utm_medium=social&utm_campaign=share